Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v6-EN
Language French English
Date Updated 2018-08-23 2017-10-27
Drug Identification Number 02314037 02314037
Brand name RAN-ROPINIROLE RAN-ROPINIROLE
Common or Proper name RAN-ROPINIROLE RAN-ROPINIROLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients ROPINIROLE ROPINIROLE
Strength(s) 0.25MG 0.25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N04BC N04BC
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-18 2017-07-18
Actual start date 2017-07-18 2017-07-18
Estimated end date 2017-11-22
Actual end date 2018-08-17
Shortage status Resolved Actual shortage
Company comments
Health Canada comments